期刊文献+

先天性甲状腺功能减退症患儿甲状腺形态学改变和治疗时机对智力发育的影响 被引量:15

Effect of thyroid morphologic change and initiating treatment time on mental development in children with congenital hypothyroidism
原文传递
导出
摘要 目的探讨先天性甲状腺功能减退症(CH)患儿甲状腺形态学改变、开始治疗时间及治疗前甲状腺功能(血FT_4、TSH浓度)对患儿智力发育的影响。方法对52例CH患儿确诊后即给予左旋甲状腺素口服,监测其智力、体格发育,并进行甲状腺核素扫描(^(99m)TcO_4)或(和)超声检查了解甲状腺形态学改变,10~30个月行Bayley婴儿发育测量法测试,得到智力发育指数(MDI)及运动发育指数(PDI)测试结果,根据治疗开始时间及形态学改变进行分组分析。结果甲状腺形态学异常组MDI明显低于甲状腺形态正常组(91±20 vs 102±15,P<0.05),患者越晚开始治疗对MDI影响越大,以61~90 d治疗者MDI(73±24)影响最为显著。结论CH患儿智力发育与甲状腺形态学改变及开始治疗时间有关,提示对筛查检出的新生儿甲减早期诊断和治疗的重要性。 Objective To explore the effect of the thyroid morphologic change, the initiating treatment time and the thyroid function ( serum FT4 ,TSH) on mental development in children with congenital hypothyroidism (CH). Methods After diagnosed, 52 cases of CH were orally administrated with L-T4, then their mental and physical development were monitored and thyroid morphologic changes were observed by thyroid imaging ( ^99mTcO4 ) and type B ultrasonography. The Bayley test was performed at the age of 10 to 30 months and expressed as mental developmental index (MDI) and psychomotor developmental index (PDI). Analysis was conducted upon treatment timing and thyroid morphologic changes. Results The MDI in those cases with morphologic abnormalities treated within 90 days was significantly lower than that with normal morphology (91 ± 20 vs 105 ± 15, P 〈 0.05). Moreover, the later the treatment is, the lower the MDI is in CH patients, especially in those treated within 61 to 90 days MDI being the lowest. Conclusion The mental, development of children with CH was related to thyroid morphologic change, function and initiation of thyroid hormone replacement, suggesting the importance of early diagnosis and treatment for CH patient.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2007年第6期498-500,共3页 Chinese Journal of Endocrinology and Metabolism
基金 上海市重点学科(T0204)
关键词 甲状腺功能减退症 先天性 治疗时间 甲状腺激素类 智力发育 Hypothyroidism, congenital Treatment time Thyroid hormones Mental development
  • 相关文献

参考文献10

  • 1Heyerdahl S, Kase BF, Lie SO. Intellectual development in children with congenital hypothyroidism in relation to recommended thyroxine treatment. J Pediatr, 1995,118:850-857.
  • 2Picketing DE, Fisher DA. Therapeutic concepts relating to hypothyroidism in childhood. J Chron Dis, 1968,7:242-263.
  • 3Klein A, Melter S, Kenney MD. Improved prognosis in congenital hypothyroidism treated before age three months. J Pediatr, 1972,8 : 912-915.
  • 4曾畿生,王德芬,主编.现代儿科内分泌学.第一版.上海:上海科学技术文献出版社,2001,189-198.
  • 5苏青,罗敏.甲状腺激素对脑发育的重要影响[J].中华内分泌代谢杂志,2003,19(5):339-340. 被引量:25
  • 6李晨阳,滕卫平,尚涛.甲状腺激素与妊娠[J].中华内分泌代谢杂志,2003,19(2):158-160. 被引量:72
  • 7Bongers-Shchokking JJ, Koot HM, Wiersma D, et al. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr, 2000,136:292-297.
  • 8路福顺.普查中发现的先天性甲状腺功能减低症的智能和运动发育预后[J].国外医学:儿科学分册,1990,:213-213.
  • 9Fisher DA. Clinical review 19: Management of congenital hypothyroidism. J Clin Endocrinol Metab, 1991,72:523-529.
  • 10杨荣旺,赵正言.先天性甲状腺功能减退症的基因基础研究进展[J].国外医学(内分泌学分册),2004,24(B05):59-62. 被引量:1

二级参考文献23

  • 1Bakker B,Bikker H,Vulsma T,et al.Two decades of screening for congenital hypothyroidism in the Netherlands: TPO mutations in total iodide organification defects(an update).J Clin Endocrinol Metab,2000,85,3708-3712.
  • 2Congdon T,Nguyen LQ,Nogueira CR,et al.A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia:evidence for phenotypic variability in mother and child.J Clin Endocrinol Metab,2001,86:3962-3967.
  • 3Iwatani N,Mabe H,Devriendt K,et al.Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure.J Pediatr,2000,137:272-276.
  • 4Van de Graaf SAR,Cammenga M,Ponne NJ,et al.The screening for mutations in the thyroglobulin cDNA from six patients with congenital hypothyroidism.Biochimie,1999,81,425-432.
  • 5Umeki K,Kotani T,Kawano J,et al.Two novel missense mutations in the thyroid peroxidase gene,R665W and G771R,result in a localization defect and cause congenital hypothyroidism.Eur J Endocrinol,2002,146:491-498.
  • 6Moreno JC,Bikker H,Kempers MJ,et al.Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism.N Engl J Med,2002,347,95-102.
  • 7Rotman-Pikielny P,Hirschberg K,Maruveda P,et al.Retention of pendrin in the endoplasmic reticulum is a major mechanism for Pendred syndrome.Hum Mol Genet,2002,11:2625-2633.
  • 8Netchine I,Sobrier ML,Krude H,et al.Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency.Nat Genet,2000,25:182-186.
  • 9Nakabayashi K,Matsumi H,Bhalla A,et al.Thyrostimulin,a heterodimer of two new human glycoprotein hormone subunits,activates the thyroid stimulating hormone receptor.J Clin Invest,2002,109: 1445-1452.
  • 10Ogasawara M,Shigetani Y,Suzuki S,et al.Expression of thyroid transcription factor-1 (TTF-1) gene in the ventral forebrain and endostyle of the agnathan vertebrate,Lampetra japonica.Genesis,2001,30:51-58.

共引文献93

同被引文献115

引证文献15

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部